ENPEP

Glutamyl aminopeptidase · Q07075 · ENPEP on Sugi Atlas →

21,164 patent compounds predicted against ENPEP, 10,048 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL197220 SCHEMBL197220 0.40 12/20
Cysteine Cysteine (SCHEMBL492744) 0.39 12/20
SCHEMBL359384 SCHEMBL359384 0.37 12/20
SCHEMBL462748 SCHEMBL462748 0.37 12/20
SCHEMBL475492 SCHEMBL475492 0.40 11/20
Cysteine Cysteine (SCHEMBL64115) 0.37 11/20
SCHEMBL456395 SCHEMBL456395 0.37 11/20
Cysteine Cysteine (SCHEMBL663460) 0.37 11/20
Cysteine Cysteine (SCHEMBL695910) 0.37 11/20
Serine Serine (SCHEMBL418635) 0.39 9/20
SCHEMBL210006 SCHEMBL210006 0.48 8/20
SCHEMBL210315 SCHEMBL210315 0.48 8/20
SCHEMBL536354 SCHEMBL536354 0.48 8/20
Glycine Glycine (SCHEMBL343653) 0.44 8/20
SCHEMBL285917 SCHEMBL285917 0.35 8/20
SCHEMBL288933 SCHEMBL288933 0.59 7/20
SCHEMBL284914 SCHEMBL284914 0.52 7/20
SCHEMBL289006 SCHEMBL289006 0.52 7/20
SCHEMBL289389 SCHEMBL289389 0.50 7/20
SCHEMBL441814 SCHEMBL441814 0.50 7/20

Clinical trials — most relevant to ENPEP by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock PHASE4COMPLETED
Effectiveness of Inactive Vitamin D Supplementation in Non-Alcoholic Fatty Liver Disease Patients PHASE3UNKNOWN
Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus PHASE2COMPLETED
Prevention of Cardiac Dysfunction During Breast Cancer Therapy PHASE2COMPLETED
Comparative Clinical Study to Evaluate the Possible Efficacy and Safety of Oral N-Acetyl Cysteine Versus Rectal Diclofenac in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis PHASE1/PHASE2COMPLETED
Aminopterin Pharmacokinetic Study In Moderate to Severe Psoriasis PHASE1COMPLETED
A Clinical Trial to Compare the Safety, Tolerability, and PK Properties of DA-5216 and DA-5216-R and to Evaluate the Food Effect on DA-5216. PHASE1UNKNOWN
Protein Digestion and Amino Acid Absorption in the Aging Gastrointestinal Tract nanCOMPLETED
An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423 nanCOMPLETED
Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC) nanUNKNOWN
New Serological Markers for Eosinophilic Esophagitis nanUNKNOWN
Neutral Endopeptidase for Early Detection of Acute Kidney Injury After Cardiac Surgery nanCOMPLETED
Causes, Complications and Outcomes of Severe Acute Liver Disease Cases Admitted to Intensive Care Units nanUNKNOWN
Safety Study of Black Cohosh Use by Postmenopausal Women on the Liver nanCOMPLETED
Natural History of Post-transfusion Non-A, Non-B Hepatitis nanCOMPLETED
Acute Hepatitis in Pediatrics nanRECRUITING
Effect of AN-PEP Enzyme on Gluten Digestion nanCOMPLETED
DPP4 Activity, Microvascular Reactivity and Inflammation nanCOMPLETED
Plasma Dipeptidyl-peptidase-4 Activities With No-reflow and Bleeding nanCOMPLETED
The PORTRAIT Study nanUNKNOWN
PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas nanCOMPLETED
Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer Patient nanRECRUITING
Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin nanCOMPLETED
Liver Function Abnormalities in Patients With Acute Heart Failure nanNOT_YET_RECRUITING
Influence of External Factors on Skeletal Growth in Youth nanACTIVE_NOT_RECRUITING
A Multicenter Selective Screening Study to Investigate the Frequency of Neuronal Ceroid Lipofuxinosis Type 2 (CLN2) nanRECRUITING
Predictive Nomogram of CRPC nanUNKNOWN
68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study nanRECRUITING
Haemostatic Imbalance in Patients With Chronic Liver Disease nanUNKNOWN
Superior Cervical Ganglion in Parkinson's Disease nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a ENPEP binder may also engage these)

ProteinNameSimilarity
A5HUI5 1.000 A5HUI5 →
P97449 1.000 P97449 →
P15145 1.000 P15145 →
Q32LQ0 1.000 Q32LQ0 →
ANPEP Aminopeptidase N 1.000 landscape →
Q95334 1.000 Q95334 →
D3UW23 1.000 D3UW23 →
P79171 1.000 P79171 →
ERAP2 Endoplasmic reticulum aminopeptidase 2 1.000 landscape →
P15541 1.000 P15541 →
Q9JJ22 0.999 Q9JJ22 →
P50123 0.998 P50123 →
O57579 0.997 O57579 →
Q9EQH2 0.997 Q9EQH2 →
P16406 0.996 P16406 →
P79143 0.995 P79143 →
P15684 0.995 P15684 →
NPEPPS Puromycin-sensitive aminopeptidase 0.995 landscape →
LNPEP Leucyl-cystinyl aminopeptidase 0.995 landscape →
Q8C129 0.994 Q8C129 →
P97629 0.993 P97629 →
P79098 0.993 P79098 →
Q6Z6L4 0.993 Q6Z6L4 →
Q6K4E7 0.993 Q6K4E7 →
ERAP1 Endoplasmic reticulum aminopeptidase 1 0.992 landscape →
Q0J5V5 0.992 Q0J5V5 →
Q5RFP3 0.992 Q5RFP3 →
A6QPT7 0.991 A6QPT7 →
P32454 0.991 P32454 →
M3XFH7 0.990 M3XFH7 →